Alsu Akramovna Sharifullina

Alsu Akramovna Sharifullina

Auto-generated profile, based on publicly available information

Alsu Akramovna Sharifullina

Federal budgetary scientific institution "Kazan Research Institute of Epidemiology and Microbiology of Rospotrebnadzor"; Federal State Autonomous Educational Institution of Higher Education "Kazan (Volga Region) Federal University"

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YTYury Tyurin
Yury Tyurin
ASAnton Shamsutdinov
Anton Shamsutdinov
NKNikolay N. Kalinin
Nikolay N. Kalinin
ASAlsou A. Sharifullina
Alsou A. Sharifullina
IRIrina D. Reshetnikova
Irina D. Reshetnikova
A whole group of polymorphisms of genes involved in the formation of the epidermal barrier, immune responses, and their regulation is important in the formation of atopic phenotype. The purpose of the study is to determine the relationship of polymorphisms of genes of Toll-like receptors TLR2 and TLR4 with clinical and immunological parameters in atopic dermatitis patients in a “case-control” study. Polymorphisms of genes TLR2 (p.Arg753Gln) and TLR4 (Asp299Gly) were detected by PCR. Parameters of the state of innate and adaptive immunity were assessed by the level of local production of sIgA, cytokine profile of blood serum for IL-4, IL-10, and IFN-γ. Biological samples from 50 people with allergic pathology, aged 4.5 to 35 years, and 100 healthy individuals (controls) were analyzed. Observed dysregulation of cytokine production (IL-4, IL-10) in patients with heterozygous polymorphic genotypes probably reflects an imbalance of Th1/Th2/Th17 regulation of immune system response in these individuals.

2 December 2023 in Russian Journal of Allergy
Verified
Journal Article
Closed access
PDF file
YTYury Tyurin
Yury Tyurin
ASAlsu Akramovna Sharifullina
Alsu Akramovna Sharifullina
IRIrina Dmitrievna Reshetnikova
Irina Dmitrievna Reshetnikova
RMRustam Amiryanovich Minnibayev
Rustam Amiryanovich Minnibayev
RKRuslan Zufarovich Khairullin
Ruslan Zufarovich Khairullin
YTYury Tyurin
Yury Tyurin
BACKGROUND: The role of local microflora in the pathogenesis of allergic rhinitis has not been sufficiently studied; therefore, the study of changes in the nasal microbiome is of interest from a scientific and practical point of view. AIM: To evaluate changes in the local microbiota of the nasal mucosa in patients with seasonal and year-round allergic rhinitis before and after pharmacological and allergen-specific therapy. MATERIALS AND METHODS: An observational retrospective single-center case-control study was conducted, which included 182 patients with allergic rhinitis. The groups were randomized according to the diagnosis (seasonal and year-round allergic rhinitis) and the therapy used: basic pharmacotherapy and allergen-specific (sublingual) immunotherapy. RESULTS: In total, 182 patients completed the study, of which 50 had seasonal allergic rhinitis, 51 had seasonal allergic rhinitis + atopic asthma (aged 7–42 years), and 81 had year-round allergic rhinitis, which included 29 aged 12–54 years and 52 with year-round allergic rhinitis + atopic asthma, aged 12–39 years. Patients with allergic rhinitis were divided into two subgroups: those who received basic therapy to achieve remission and those who received allergen-specific (sublingual) immunotherapy. After basic therapy, the abundance of Staphylococcus aureus in the local microbiota of the upper respiratory tract in patients with seasonal allergic rhinitis decreased by 1.4 times; in the allergen-specific (sublingual) immunotherapy group, its abundance more significantly decreased (3.9 times; p 0.05). In the group with year-round allergic rhinitis, the same pattern was noted. In the group with seasonal allergic rhinitis and year-round allergic rhinitis and the group with both allergen-specific (sublingual) immunotherapy and atopic asthma who received a full course of allergen-specific (sublingual) immunotherapy, the activation index of blood basophils by rSplA-proteinase S. aureus was reduced by 1.2–1.5 compared with the value in those who received basic pharmacotherapy. CONCLUSION: Patients with allergic rhinitis exhibited quantitative and qualitative significant changes in the microbiome of the upper respiratory tract mucosa, one of the consequences of which is the development of IgE-mediated sensitization to S. aureus products. Allergen-specific immunotherapy for patients with allergic rhinitis leads to decreased colonization of the nasal mucosa with S. aureus and decreased sensitization to rSplA proteinase.